Literature DB >> 16474159

Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.

Samuel Victor Nuvor1, Marianne van der Sande, Sarah Rowland-Jones, Hilton Whittle, Assan Jaye.   

Abstract

Natural killer (NK) cells are potent effectors of natural immunity and their activity prevents human immunodeficiency virus type 1 (HIV-1) viral entry and viral replication. We sought to determine whether NK immune responses are associated with different clinical course of HIV-1 and HIV-2 infections. A cross-sectional analysis of NK cell responses was undertaken in 30 HIV-1 and 30 HIV-2 subjects in each of three categories of CD4(+)-T-cell counts (>500, 200 to 500, and <200 cells/microl) and in 50 HIV-uninfected control subjects. Lytic activity and gamma interferon (IFN-gamma) secretion were measured by chromium release and enzyme-linked immunospot assays, respectively. Flow cytometry was used to assess intracellular cytokines and chemokines. Levels of NK cytotoxicity were significantly higher in HIV-2 than in HIV-1 infections in subjects with high CD4(+)-T-cell counts and were similar to that of the healthy controls. In these HIV-2 subjects, cytolytic activity was positively correlated to NK cell count and inversely related to plasma viremia. Levels of intracellular MIP-1beta, RANTES, tumor necrosis factor alpha, and IFN-gamma produced by NK CD56(bright) cells were significantly higher in HIV-2- than HIV-1-infected subjects with high CD4(+)-T-cell counts but fell to similar levels as CD4 counts dropped. The data suggest efficient cytolytic and chemokine-suppressive activity of NK cells early in HIV-2 infection, which is associated with high CD4(+) T-cell counts. Enhancement of these functions may be important in immune-based therapy to control HIV disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474159      PMCID: PMC1395408          DOI: 10.1128/JVI.80.5.2529-2538.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Authors:  B Lowin; M Hahne; C Mattmann; J Tschopp
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

2.  An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status.

Authors:  A L Landay; C E Mackewicz; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1993-10

3.  HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Côte d'Ivoire.

Authors:  K Odehouri; K M De Cock; J W Krebs; J Moreau; M Rayfield; J B McCormick; G Schochetman; R Bretton; G Bretton; D Ouattara
Journal:  AIDS       Date:  1989-08       Impact factor: 4.177

4.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

5.  Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.

Authors:  L T Ratcliffe; P T Lukey; C R MacKenzie; S R Ress
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

6.  Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.

Authors:  Anna Linda Hultström; Göran Bratt; Antonio Cosma; Volker Erfle; Britta Wahren; Ennio Carbone
Journal:  Immunol Lett       Date:  2004-02-15       Impact factor: 3.685

7.  HIV-2-infected patients survive longer than HIV-1-infected patients.

Authors:  H Whittle; J Morris; J Todd; T Corrah; S Sabally; J Bangali; P T Ngom; M Rolfe; A Wilkins
Journal:  AIDS       Date:  1994-11       Impact factor: 4.177

8.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Authors:  R Marlink; P Kanki; I Thior; K Travers; G Eisen; T Siby; I Traore; C C Hsieh; M C Dia; E H Gueye
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

9.  No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.

Authors:  Assan Jaye; Ramu Sarge-Njie; Maarten Schim van der Loeff; Jim Todd; Abraham Alabi; Shehu Sabally; Tumani Corrah; Hilton Whittle
Journal:  J Infect Dis       Date:  2004-01-21       Impact factor: 5.226

10.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Authors:  W E Carson; J G Giri; M J Lindemann; M L Linett; M Ahdieh; R Paxton; D Anderson; J Eisenmann; K Grabstein; M A Caligiuri
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  13 in total

1.  An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.

Authors:  A Eshofonie; M Shim van der Loeff; H Whittle; A Jaye
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

2.  Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.

Authors:  Pavel Bostik; Jaruda Kobkitjaroen; Weining Tang; Francois Villinger; Lara E Pereira; Dawn M Little; Susan T Stephenson; Mark Bouzyk; Aftab A Ansari
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

4.  Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.

Authors:  Biswanath Majumder; Narasimhan J Venkatachari; Shaylee O'Leary; Velpandi Ayyavoo
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

5.  Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.

Authors:  Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun-Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

Review 6.  Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.

Authors:  Nadia Chanzu; Beatrice Ondondo
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

7.  Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.

Authors:  Susanna M Bächle; David F G Malone; Marcus Buggert; Annika C Karlsson; Per-Erik Isberg; Antonio J Biague; Hans Norrgren; Patrik Medstrand; Markus Moll; Johan K Sandberg; Marianne Jansson
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

8.  Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection.

Authors:  Suha Saleh; Lenard Vranckx; Rik Gijsbers; Frauke Christ; Zeger Debyser
Journal:  J Virus Erad       Date:  2017-01-01

9.  Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection.

Authors:  Marco Iannetta; Stéphane Isnard; Jennifer Manuzak; Jean-Baptiste Guillerme; Mathilde Notin; Karine Bailly; Muriel Andrieu; Sonia Amraoui; Lene Vimeux; Suzanne Figueiredo; Bénédicte Charmeteau-de Muylder; Laura Vaton; Etienne X Hatton; Assia Samri; Brigitte Autran; Rodolphe Thiébaut; Nathalie Chaghil; David Glohi; Charlotte Charpentier; Diane Descamps; Françoise Brun-Vézinet; Sophie Matheron; Remi Cheynier; Anne Hosmalin
Journal:  Front Immunol       Date:  2020-08-13       Impact factor: 7.561

10.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.